Clinical Trials Sponsored by Parker Research Institute
Total 18890 results
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myeloma | Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer | Extragonadal Germ Cell Tumor | Carcinoma of Unknown PrimaryUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedPain | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedQuality of Life | Palliative Care | Outcome Assessment | Pediatric NeoplasmUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedSarcoma | Brain and Central Nervous System Tumors | Gastrointestinal Stromal TumorUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)UnknownMelanoma (Skin)United States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)UnknownHead and Neck CancerUnited States
-
Baker Heart and Diabetes InstituteNot yet recruitingHeart Failure | Cognitive Impairment | Dementia | Cognitive Change | Cognitive Decline | Left Ventricular Dysfunction
-
Baker Heart and Diabetes InstituteCompleted
-
Baker Heart and Diabetes InstituteTerminated
-
Baker Heart and Diabetes InstituteTerminatedPeripheral Arterial Disease | Intermittent ClaudicationAustralia
-
Dana-Farber Cancer InstituteAbbott NutritionRecruiting
-
Wenxin XuRecruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteRegeneron PharmaceuticalsActive, not recruitingAdvanced Cancer | Cutaneous Squamous Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Dana-Farber Cancer InstitutePrometheus LaboratoriesActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
Dana-Farber Cancer InstituteMayo ClinicActive, not recruiting
-
Dana-Farber Cancer InstituteGilead SciencesActive, not recruitingBladder Cancer | Urothelial Cancer | Metastatic Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedProstate Cancer | Prostate Adenocarcinoma | High Risk Prostate CancerUnited States
-
Eye PharmaBascom Palmer Eye InstituteCompleted
-
Dana-Farber Cancer InstituteGE HealthcareTerminatedAtypical Ductal HyperplasiaUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompleted
-
AEterna ZentarisDana-Farber Cancer InstituteTerminatedMultiple MyelomaIsrael, Spain, Korea, Republic of, United States, Russian Federation, Canada, Ireland, Czechia, Slovakia
-
Dana-Farber Cancer InstituteCelgene CorporationTerminatedSquamous Cell Carcinoma of the Head and Neck | Basaloid Squamous Cell Carcinoma | Undifferentiated Carcinoma | Adenosquamous Cell Carcinoma
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Dana-Farber Cancer InstituteMedWaves, IncNot yet recruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingSalivary Gland Cancer | HER2 Gene MutationUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingRichter SyndromeUnited States
-
Dana-Farber Cancer InstituteJanssen PharmaceuticaActive, not recruitingProstate CancerUnited States
-
Dana-Farber Cancer InstituteCuris, Inc.Active, not recruitingLymphoma | Solid Tumor | Brain Tumor | NeuroblastomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Dana-Farber Cancer InstitutePharmacyclics LLC.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedHypopharyngeal Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Early Invasive Cervical Squamous Cell Carcinoma | Cancer of Nasopharynx | Carcinoma of LarynxUnited States
-
Dana-Farber Cancer InstituteCURE FoundationCompletedBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedTuberous Sclerosis Complex | TSC1 | TSC2 | MTORUnited States
-
Dana-Farber Cancer InstituteCelula, Inc.TerminatedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Dana-Farber Cancer InstituteDaisy FoundationCompleted
-
AEterna ZentarisDana-Farber Cancer InstituteCompletedWaldenström's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteGilead SciencesTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Baker Heart and Diabetes InstituteRecruitingHeart FailureAustralia
-
Baker Heart and Diabetes InstituteRecruitingCoronary Artery DiseaseAustralia
-
Baker Heart and Diabetes InstituteWithdrawn
-
Baker Heart and Diabetes InstituteRecruiting
-
Baker Heart and Diabetes InstituteCompletedDiabetic NephropathiesAustralia